In India, Covaxin has been approved for children and minors

International Desk: Kovacin has received initial approval for use in corona vaccination programs for children and minors in India. The country's national daily Hindustan Times reported this information.

The subject matter expert committee (SEC), a panel of experts formed by the Indian government to prevent the corona epidemic, on Tuesday approved the use of covacin for the country's 2 to 18-year-olds, the report said.

All that remains is the approval of the Drug Controller General of India (DGCI), India's central drug regulator. Once this is done, doses of covacin will be used to vaccinate children and minors in the country. However, it is hoped that the DGCIO will complete the formalities soon.

The first corona ticker to be approved by DGCI for children and minors in India was named Jaidas Cadila. It is a DNA protein-based vaccine, a chemical used in the preparation of this vaccine, which enters the human body to form corona-resistant proteins.

Covacin vaccine, on the other hand, has been used to make the scientifically modified coronavirus, which, when ingested into the human body, automatically builds up the immune system.

The vaccine was developed by Bharat Biotech, a pharmaceutical and vaccine company based in Hyderabad, the capital of the southern Indian state of Telangana. On January 3, Kovacin was approved by the DCGI for use in adults in case of emergency.

Officials at Bharat Biotech said the company has so far conducted three age-based trials to get approval for use in children and minors. The first trial was conducted between 12 to 18 year olds, the second trial was conducted between 6 to 12 year olds and the third trial was conducted between 2 to 6 year olds.

Among the experts who reviewed the results of the trials was Sanjay K. Roy, a professor in the Department of Community Medicine at the All India Institute of Medical Sciences (AIIMS), India's highest government medical institution. "The results of the covacin trial are satisfactory," he told the Hindustan Times.

Comments (0)